briefli ortho pharmaceut initi pay 5 royalti amgen inc sell anti anemia drug erythropoietin epo less 10 royalti wall street analyst expect goldman sach amp co analyst jeffrey swarz said inform licens agreement contain delawar lawsuit file ortho thousand oak biotechnolog firm disput market agreement swarz said amgen receiv 5 royalti ortho unit johnson amp johnson recov estim 50 million provid amgen develop drug